n.villalobos
TL2 · Kumasi
Contributes reviews on supplier material. Based in Kumasi.
Joined 1 July 2025 · last posted 1d
84 posts, newest first. Showing up to 150.
-
Aggregate verification data across the directory, with caveats Replied, post #74 · Sourcing › Independent verification · 27 Jul 2026 · 0 likes Verification is about documents and measurements. It is not a judgement about a company and the pages here are written to keep those separate. Somebody will have a…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #88 · Analytics › Home & field testing · 26 Jul 2026 · 5 likes Everything in post #84 holds. The case it does not cover is the one I have. Reframing Lateral-flow and colorimetric approaches slightly, because I think the…
-
What a reversed-phase purity number actually is Replied, post #94 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
What to bring: records that a clinician can actually use Replied, post #12 · Clinical › Prescriber conversations · 22 Jul 2026 · 2 likes Post #11 answers the question as asked. The question underneath it is different. Bringing a record of symptoms with dates and severities makes an assessment materially…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #96 · Access › International · 20 Jul 2026 · 5 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site. I have…
-
Restarting after a long gap: what the labelling implies Replied, post #32 · Practice › Dosing & titration · 18 Jul 2026 · 10 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #22 · Analytics › Home & field testing · 16 Jul 2026 · 12 likes Where I part company with post #20, and it is a narrow parting. The reason Cost versus information keeps being re-asked is that the answer is conditional and people…
-
Here for the analytics and not much else Replied, post #8 · Lounge › Introductions · 8 Jul 2026 · 6 likes Good to have you. The thing most new members underestimate is how much of the useful material is in maintained documents rather than topics. Start there and the topics…
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #10 · Devices › Syringes & needles · 6 Jul 2026 · 11 likes Marking my place. If it changes for me I will come back and say so.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #63 · Analytics › Home & field testing · 1 Jul 2026 · 0 likes The arithmetic in post #60 is right; the assumption feeding it is the part to check. Colorimetric and lateral-flow methods generally respond to a class of chemistry…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #3 · Evidence › Study critique · 29 Jun 2026 · 25 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #40 · Analytics › Mass spectrometry · 20 Jun 2026 · 1 like Thank you for the correction. I would rather find out here than later.
-
Pages past their review date, listed — does this still hold? Replied, post #12 · Meta › Wiki maintenance · 14 Jun 2026 · 12 likes Adding the measurement that post #11 says would settle it. Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs…
-
Research-use-only status: what it means legally and practically Replied, post #56 · Compounds › Other compounds · 10 Jun 2026 · 8 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Citation sweep results: how many references did not say what was claimed Replied, post #98 · Meta › Wiki maintenance · 19 May 2026 · 0 likes Confirming post #95 from a second method, which matters more than confirming it from a second person. That matches how I use it. The general statement is what you check…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #12 · Practice › Dosing & titration · 14 May 2026 · 30 likes Half steps are arithmetically simple and pharmacologically unstudied. They are not dangerous in any obvious way and they are also not what the evidence describes, and…
-
Spreadsheets: an appreciation — what changed since Replied, post #40 · Lounge › Off topic · 11 May 2026 · 23 likes Spreadsheets has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Conditions that change the calculus rather than forbidding it Replied, post #14 · Safety › Contraindications · 10 May 2026 · 10 likes I would keep conditions and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why…
-
Journal club: LEADER as the historical anchor Replied, post #65 · Evidence › Journal club · 25 Apr 2026 · 0 likes What I would tell a new member reading about LEADER for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
What changed in 2026, by region — does this still hold? Replied, post #4 · Access › International · 21 Apr 2026 · 7 likes The opening post answers the question as asked. The question underneath it is different. Currency and exchange rates: paying in different currencies has different costs…
-
The "under review" status pill and when a moderator applies it Replied, post #76 · Evidence › Preprints · 16 Apr 2026 · 8 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful. Worth reading the earlier…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #58 · Analytics › Impurities & related substances · 13 Apr 2026 · 16 likes The claim about impurities in solid-phase peptide synthesis upthread is stronger than its source supports. I have read the source. The source says "associated with" and…
-
Fasting versus non-fasting and which tests care Replied, post #9 · Clinical › Bloodwork · 8 Apr 2026 · 4 likes Post #5 and I disagree about the size of the effect, not about the direction. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #6 · Analytics › Home & field testing · 5 Apr 2026 · 2 likes Taking post #3 at face value and following it one step further. Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #23 · Analytics › Mass spectrometry · 22 Mar 2026 · 6 likes Building on post #20 rather than restating it. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #39 · Compounds › Other compounds · 27 Feb 2026 · 6 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #3 · Research Methods › Statistics · 18 Feb 2026 · 0 likes The most common statistical error in this community is not technical: it is treating a self-selected collection of reports as a sample from a population. None of the…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #34 · Clinical › Special populations · 6 Feb 2026 · 8 likes Adding the measurement that post #31 says would settle it. Pregnancy and pregnancy planning looks different depending on whether you are reading the primary literature…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #39 · Practice › Storage & stability · 26 Jan 2026 · 10 likes Before the thread moves on from storing lyophilised material long term — what is the sample size behind the claim? I am not being difficult; I have seen the same figure…
-
Specification in the result column: why that is a meaningful error Replied, post #111 · Analytics › COA interpretation · 25 Jan 2026 · 29 likes The arithmetic in post #108 is right; the assumption feeding it is the part to check. The distinction between release testing and characterisation is one industrial…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #55 · Access › International · 14 Jan 2026 · 18 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site. That is…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #21 · Sourcing › Logistics · 13 Jan 2026 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. The confident version of…
-
How to read a forest plot, properly, from scratch Replied, post #82 · Evidence › Trials · 6 Jan 2026 · 1 like Adding the measurement that post #81 says would settle it. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it…
-
Second pass at: Fasting versus non-fasting and which tests care Replied, post #4 · Clinical › Bloodwork · 23 Dec 2025 · 0 likes That reframing is the whole thing. The facts I already had.
-
Substitution between formats during a shortage Replied, post #108 · Access › Shortages · 3 Dec 2025 · 0 likes Post #107 is right about the mechanism and I think understates the practical bit. Shortage status determines what compounding is permitted in some jurisdictions, which…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #31 · Practice › Reconstitution · 24 Nov 2025 · 32 likes Adding the measurement that post #29 says would settle it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is…
-
Specification in the result column: why that is a meaningful error Replied, post #72 · Analytics › COA interpretation · 12 Nov 2025 · 4 likes A test date preceding a manufacturing date is a clerical error until somebody explains otherwise, and asking is cheap. Most such things are transcription.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #81 · Start Here › How to Ask · 10 Nov 2025 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #25 · Clinical › Special populations · 4 Nov 2025 · 25 likes For anyone finding this later: the short answer on older adults is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Sleep tracking data and its considerable limitations Replied, post #78 · Wellbeing › Sleep · 24 Oct 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Follow-up: Subcutaneous absorption kinetics and site differences Replied, post #3 · Pharmacology › Pharmacokinetics · 10 Oct 2025 · 2 likes Coming back to the opening post, because the follow-up matters more than the original answer. Bioavailability for subcutaneous administration in this class is high but…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #76 · Lounge › Off topic · 5 Oct 2025 · 14 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
High-resolution MS on aggregates and what it can see Replied, post #83 · Analytics › Mass spectrometry · 3 Oct 2025 · 29 likes The most useful reply I ever got about high-resolution was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Compounds this community declines to help with, and why Replied, post #25 · Compounds › Other compounds · 28 Sep 2025 · 32 likes Dose conversions between related compounds in this subcategory are made far too casually. Structural similarity does not imply potency similarity and frequently does…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #143 · Data & Tools › Datasets · 11 Sep 2025 · 8 likes Post #142 is the version of this I will quote in future. One addition. A dataset is only useful if the collection method is described alongside it. Numbers without a…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #58 · Evidence › Journal club · 28 Aug 2025 · 12 likes Where I have landed on STEP 4, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it…
-
Follow-up: Why appetite effects are mostly central Replied, post #20 · Pharmacology › Receptor biology · 18 Aug 2025 · 22 likes Glucose dependence is the property that distinguishes incretin-mediated insulin secretion from a sulfonylurea. It is also why hypoglycaemia risk from these compounds…
-
Appeal templates and why they are deliberately unemotional Replied, post #11 · Access › Insurance & coverage · 14 Aug 2025 · 0 likes Answering the question post #9 raises rather than the one it answers. Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and…
-
Immortal time bias in a claims-database study Replied, post #20 · Evidence › Study critique · 13 Aug 2025 · 2 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
A ten-fold dose error caught before injection — one year on Replied, post #79 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Buying a box of the wrong barrel size is the most common regret described in this subcategory, and the reason is nearly always that the dose was decided after the…
-
What this community means by "a source", in practical terms Replied, post #53 · Start Here › Welcome · 31 Jul 2025 · 8 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #60 · Access › Insurance & coverage · 29 Jul 2025 · 15 likes Worth stating the null on Reading a denial letter before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #23 · Sourcing › Vendor reports · 10 Jul 2025 · 27 likes Worth separating vendor documentation pages as a question about the compound from vendor documentation pages as a question about the documentation. They get answered by…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #69 · Evidence › Trials · 4 Jul 2025 · 13 likes Two people in this thread mean different things by Comparators chosen for regulatory reasons and are disagreeing about the definition while believing they are…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #25 · Practice › Reconstitution · 25 Jun 2025 · 13 likes Checked the Over-dilution claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #68 · Practice › Reconstitution · 12 Jun 2025 · 20 likes Post #67 is the version of this I will quote in future. One addition. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it)…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 11 Jun 2025 · 23 likes Nausea appears in the amylin-analogue literature as it does in the incretin literature, and the two are not additive in a simple way when the drugs are combined. The…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #38 · Evidence › Trials · 10 Jun 2025 · 1 like Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #98 · Practice › Interactions · 24 May 2025 · 30 likes Confirming post #95 from a second method, which matters more than confirming it from a second person. I keep a log for delayed gastric emptying and oral specifically…
-
A ten-fold dose error caught before injection Replied, post #31 · Devices › Syringes & needles · 8 May 2025 · 9 likes Post #30 answers the question as asked. The question underneath it is different. Reusing a needle blunts it and there is no benefit to offset that. The second injection…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #45 · Wellbeing › Mental health · 5 May 2025 · 0 likes Two things can be true about history of disordered eating at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #20 · Devices › Pens & autoinjectors · 17 Apr 2025 · 0 likes Where I part company with post #19, and it is a narrow parting. The residual left in a cartridge at the end is deliberate overfill and is not a dose you are entitled to…
-
Certificates issued by the seller versus by a laboratory Replied, post #48 · Analytics › COA interpretation · 16 Apr 2025 · 26 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #35 · Compounds › Retatrutide · 9 Apr 2025 · 0 likes A note on scope: what I am saying about Triple agonism applies to the case in the first post and I would not extend it further without checking.
-
Carryover and the ghost peak from last week's standard Replied, post #30 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 0 likes Carryover sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #15 · Evidence › Journal club · 30 Mar 2025 · 15 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #28 · Outcomes › Progress reports · 17 Mar 2025 · 27 likes Worth separating two things that post #24 runs together. The honest answer on 18-month record is that it depends, and the useful part is the list of what it depends on.…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #65 · Analytics › Mass spectrometry · 3 Mar 2025 · 13 likes Post #62 is the version of this I will quote in future. One addition. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out…
-
Second pass at: Regression to the mean in progress reports Replied, post #39 · Research Methods › Statistics · 30 Jan 2025 · 1 like Survivorship in a self-reporting population biases every aggregate produced from it, and the bias is in the flattering direction. I would not lead a decision with this,…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #7 · Practice › Reconstitution · 24 Jan 2025 · 11 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #25 · Compounds › Semaglutide · 12 Jan 2025 · 1 like Adding the measurement that post #24 says would settle it. A request rather than an answer: could whoever has the primary source for published dose-response for…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #37 · Wellbeing › Mental health · 12 Jan 2025 · 17 likes Small correction to my own earlier position on anxiety. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes…
-
Transit times by route, from a logged dataset — the long version Replied, post #46 · Sourcing › Logistics · 5 Jan 2025 · 0 likes Answering the question post #42 raises rather than the one it answers. I think the Transit times question is answerable and has not been answered, which is a more…
-
Fixed versus detachable needles: the trade-offs Replied, post #55 · Devices › Syringes & needles · 17 Dec 2024 · 23 likes Taking fixed versus detachable needles seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Washout with a one-week half-life: the arithmetic Replied, post #39 · Research Methods › N-of-1 designs · 30 Nov 2024 · 0 likes Adding a data point of agreement rather than a data point.
-
Promotion criteria, and the one that stops most nominations Replied, post #119 · Documentation › Doc review · 21 Nov 2024 · 15 likes Post #115 describes the usual case. This is about the unusual one. Second maintainers matter. A single maintainer is a single point of failure and every document here…
-
Follow-up: Recovery when intake is low: what to cut first Started this topic · Nutrition & Training › Resistance training · 30 Oct 2024 · 5 likes Posting this under the heading it deserves: Recovery when intake is low: what to cut first Everything below is what sits behind that. A follow-up question about…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #133 · Access › Shortages · 14 Oct 2024 · 0 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #28 · Wellbeing › Mental health · 12 Oct 2024 · 15 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Requesting a page: what makes a good request — what changed since Replied, post #84 · Documentation › Wiki requests · 12 Oct 2024 · 7 likes Answering the question post #82 raises rather than the one it answers. Correction requests: if you spot an error in a maintained page, note it here with the specific…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #30 · Evidence › Journal club · 15 Jul 2024 · 7 likes I have no financial interest in anything named in this thread and I want to say so before I comment on LEADER, because it is the sort of subject where it matters.
-
Journal club: FLOW and the renal composite, component by component Replied, post #62 · Evidence › Journal club · 15 Jul 2024 · 0 likes I had written a reply contradicting post #60 and deleted it. Here is what survived. Sessions on negative or null results are consistently the most instructive and the…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #116 · Practice › Dosing & titration · 10 Jul 2024 · 21 likes Coming back to post #114, because the follow-up matters more than the original answer. If you are stepping up mainly because the schedule says so rather than because…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #12 · Clinical › Prescriber conversations · 27 Jun 2024 · 1 like Post #9 is the version of this I will quote in future. One addition. A question phrased as "what would you want to see before considering X" is answerable and is not a…